Greetings from MyCancerHaven!

We wanted to update you on our recent activities.

Here are the latest posts last week:

‍Blogs :

Education Level, Social Media Awareness May Be Linked to Cancer Fatalism

‍CD22 CAR-T Therapy Could Be a Future Option for CD19-Refractory LBCL

‍Reducing Infections in Patients With CLL, NHL

‍Glofitamab Combination Therapy Shows Survival Benefit

‍"Once you choose hope, anything’s possible."

‍Extranodal Marginal Zone Lymphoma: Is Overtreatment Common?

‍Also at MCH the News and Tweets never stop flowing!

Join Us at www.mycancerhaven.org

‍The Team @ MCH

Follow us on Facebook, Twitter (@My_Cancer_Haven), Instagram, YouTube, LinkedIn and TikTok

Note: Please do not reply to this e-mail as it is sent from an account that is not monitored. You can contact us by e-mail at contact@mycancerhaven.org.